Macquarie Begins Coverage on Corteva (NASDAQ:CTVA)

Macquarie assumed coverage on shares of Corteva (NASDAQ:CTVA) in a research report sent to investors on Tuesday, June 4th, The Fly reports. The brokerage issued an outperform rating on the stock.

CTVA has been the subject of several other research reports. Morgan Stanley began coverage on Corteva in a research note on Monday, June 3rd. They issued an equal weight rating and a $32.00 target price for the company. SunTrust Banks began coverage on Corteva in a research note on Monday, June 3rd. They issued a hold rating and a $29.00 target price for the company. Goldman Sachs Group began coverage on Corteva in a research report on Monday, June 3rd. They set a neutral rating and a $29.00 price target for the company. Citigroup began coverage on Corteva in a research report on Monday, June 3rd. They set a neutral rating and a $29.00 price target for the company. Finally, Jefferies Financial Group began coverage on Corteva in a research report on Wednesday, May 29th. They set a buy rating for the company. Eight equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock presently has a consensus rating of Hold and an average price target of $31.27.

Shares of Corteva stock remained flat at $$29.57 during trading hours on Tuesday. The stock had a trading volume of 15,517,796 shares, compared to its average volume of 9,500,546. Corteva has a 1 year low of $24.35 and a 1 year high of $32.00.

In related news, Director Gregory R. Page purchased 2,000 shares of the firm’s stock in a transaction on Monday, June 3rd. The shares were acquired at an average cost of $25.49 per share, with a total value of $50,980.00. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

See Also: Stock Symbols, CUSIP and Other Stock Identifiers

The Fly

Analyst Recommendations for Corteva (NASDAQ:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.